We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
101
Baker Bros. Advisors
New York
$3.07M – – –
Envestnet Asset Management
102
Envestnet Asset Management
Illinois
$3.07M +$488K +9,393 +24%
State of New Jersey Common Pension Fund D
103
State of New Jersey Common Pension Fund D
New Jersey
$3.04M – – –
MOACM
104
Mutual of America Capital Management
New York
$3.04M +$2.51M +48,330 New
AIG
105
American International Group
New York
$2.93M -$9.76K -188 -0.4%
Baird Financial Group
106
Baird Financial Group
Wisconsin
$2.73M +$2.26M +43,457 New
Ameriprise
107
Ameriprise
Minnesota
$2.67M +$1.6M +30,846 +264%
CUAMC
108
China Universal Asset Management Company
China
$2.65M -$12.6K -243 -0.6%
AGP
109
Artia Global Partners
Florida
$2.42M – – –
CAC
110
Cowen and Company
New York
$2.39M +$1.98M +38,092 New
BBHC
111
Brown Brothers Harriman & Co
New York
$2.39M – – –
MIM
112
Monashee Investment Management
Massachusetts
$2.35M +$1.95M +37,500 New
Prudential Financial
113
Prudential Financial
New Jersey
$2.29M +$12.6K +243 +0.7%
Wells Fargo
114
Wells Fargo
California
$2.25M -$1.28M -24,595 -41%
Dimensional Fund Advisors
115
Dimensional Fund Advisors
Texas
$2.16M -$326K -6,276 -15%
EAM
116
Erste Asset Management
Austria
$2.13M +$239K +4,600 +16%
Susquehanna International Group
117
Susquehanna International Group
Pennsylvania
$1.93M +$467K +8,993 +41%
Point72 Asset Management
118
Point72 Asset Management
Connecticut
$1.89M -$32.3M -621,030 -95%
Royal Bank of Canada
119
Royal Bank of Canada
Ontario, Canada
$1.8M +$873K +16,804 +141%
GC
120
Guggenheim Capital
Illinois
$1.73M -$142K -2,729 -9%
PA
121
Profund Advisors
Maryland
$1.71M -$83.2K -1,602 -6%
CCIA
122
Campbell & Co Investment Adviser
Maryland
$1.71M +$45.5K +877 +3%
State Board of Administration of Florida Retirement System
123
State Board of Administration of Florida Retirement System
Florida
$1.68M – – –
AAA
124
Affinity Asset Advisors
New York
$1.57M – – –
Alyeska Investment Group
125
Alyeska Investment Group
Illinois
$1.57M – – –
3 4
5
6 7

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.